This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
GKN (GKN.L) – Better-than-expected 5% rise in first half profit, led by a strong performance from its aerospace business. Pretax profit of £278m, ahead of the average analyst forecast of £272m. Increased the interim dividend by 8% to 2.6p and said revenues grew 12% to £3.87bn. Closing Price 327.60p (Reuters)
BP (BP.L) – Increased its giant accounting provision for the 2010 oil spill to $42.4bn from $42.2bn and said its $20bn fund to pay spill compensation had only $300m left in it. The news came as BP’s second quarter results missed expectations, with adjusted net profit coming in at $2.712bn compared with expectations of $3.410bn. Closing Price 467.40p (Reuters)
Barclays (BARC.L) – H1 pretax profit down 17% at £3.59m missing estimates. Announces rights issue to raise £5.8bn. One-for-four at 185p. £12.8bn shortfall in PRA Leverage Ratio requirement. Closing price 309.05p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| WPP | WPP.L | 0.60% | 4.77% | 0.26% |
| Reckitt Benckiser | RB.L | -0.82% | 1.60% | -1.64% |
| Randgold Resources | RRS.L | 3.42% | 3.71% | -0.56% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research